BCP
WVE icon

Berylson Capital Partners’s Wave Life Sciences WVE Stock Holding History

Berylson Capital Partners’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-152,228
Closed -$3.13M – 41
2019
Q3 		$3.13M Hold
152,228
– – 7.86% 5
2019
Q2 		$3.97M Hold
152,228
– – 7.14% 5
2019
Q1 		$5.91M Hold
152,228
– – 7% 3
2018
Q4 		$6.4M Sell
152,228
-10,010
-6% -$445K 15.65% 1
2018
Q3 		$8.11M Hold
162,238
– – 16.01% 2
2018
Q2 		$6.21M Hold
162,238
– – 7.67% 4
2018
Q1 		$6.51M Hold
162,238
– – 18.45% 1
2017
Q4 		$5.7M Buy
+162,238
New +$4.73M 8.77% 1

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Berylson Capital Partners's WVE Position: Q4 2019 in Review

Berylson Capital Partners sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 152,228 shares — an estimated $3.13M sold.

Berylson Capital Partners first reported a position in WVE in Q4 2017 and held it in 8 quarters. The position peaked at $8.11M in Q3 2018. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • Berylson Capital Partners reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Berylson Capital Partners sold 152,228 Wave Life Sciences shares in Q4 2019, an estimated $3.13M.
  • Berylson Capital Partners first reported a position in Wave Life Sciences in Q4 2017 and held it in 8 quarters.
  • Berylson Capital Partners's Wave Life Sciences position peaked at $8.11M in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on Berylson Capital Partners's 13F filing for Q4 2019, filed 14 Feb 2020.